Expertise in conditions including:
Neuromuscular conditions
Muscle pain
Genetic muscle conditions
Pins and needles
Neuropathy
Myasthenia
Myotonia
Myotonic dystrophy
Neurotoxicity - side effects of chemotherapy/cancer treatment
Headache
Weakness
Parkinsons disease
Epilepsy
Movement Disorders
Awards
2022 MDUK Early career Researcher of the year 2022
2022 UCL Research Culture Awards
2021 Association of British Neurologists 2021 Top Platform Presentation Prize
2020 Fastrack Grant (BRC & UCLH Charities)
2020 Muscle Study Group Conference Shark Tank Winner
2007 Clinical Skills in Medicine Award. Southern Clinical School.
2007 Invited to the Golden Key International Honour Society
2007 Consideration for the Year 2 Portfolio Prize
2006 Cardinal Knox Scholarship. Mannix College.
2005 John Flynn Scholarship Scheme
2004 Order of Australia Student Citizenship Award
2004 TJ Ryan Scholarship
2004 Australian Students Prize for Excellence. - Awarded to the top 500 students in the nation.
2004 Inaugural Peter Doherty Senior Science Student Award
2004 Lions Youth of the Year, Regional Finals Winner, Queensland
2003 Rostrum Voice of Youth Public Speaking State Finalist, Queensland
2002 Inter-school Debating Winner, North Queensland
2002 Rostrum Voice of Youth Public Speaking State Semi-Final Runner-up, Queensland
Publications
1. Vivekanandam V, et al. (2024) Mexiletine versus lamotrigine in non-dystrophic myotonias: a head-to-head, randomised phase III non-inferiority trial. Lancet Neurology. Volume 23, Issue 10, 1004 - 1012
2. Vivekanandam V, …. Hanna M. (2023) Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation. Muscle and Nerve. DOI:10.1002/mus.27947
3. Vivekanandam V, Jayaseelan D, Hanna M. (2023) Chapter 21 - Muscle channelopathies. Handbook of Clinical Neurology. Elsevier. 195; 521-532. doi.org/10.1016/B978-0-323-98818-6.00006-6.
4. Vivekanandam V, Jaibaji R … Hanna M. (2023). Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing. Neuromuscular Disorders. doi.org/10.1016/j.nmd.2023.01.007.
5. Vivekanandam V., Jayaseelan D., Hanna M. (2022). COVID-19 infection and vaccination in patients with skeletal muscle channelopathies. Muscle and Nerve. doi.org/10.1002/mus.27704
6. Vivekanandam V….Hanna, M. (2022). In silico predictive tools are poor predictors compared to in vivo functional characterisation of genetic variants - lessons from muscle channelopathies and implications for genomic medicine. Brain. doi.org/10.1093/brain/awac431
7. Vivekanandam V., Jayaseelan D., Munot P., Hanna M. (2022). Chapter to The Handbook of Clinical Neurology, Elsevier. “Paediatric Neuromuscular Channelopathies”.
8. Vivekanandam V., … Hanna, M. & Matthews, E. (2022). Andersen-Tawil Syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity. Brain. doi.org/:10.1093/brain/awab445
9. Vivekanandam, V., Bugiardini, E., Merve, A., Parton, M., Morrow, J. M., Hanna, M. G., & Machado, P. M. (2020). Differential Diagnoses of Inclusion Body Myositis. Neurologic Clinics, 38 (3), 697-710. doi:10.1016/j.ncl.2020.03.014
10. Vivekanandam, V., Mannikko, R., Matthews, E., & Hanna, M. G. (2020). Improving genetic diagnostics of skeletal muscle channelopathies. Expert Review of Molecular Diagnostics. Jul;20(7):725-736. doi: 10.1080/14737159.2020.1782195.
11. Vivekanandam, V., Munot, P., Hanna, M., & Matthews, E. (2020). Skeletal Muscle Channelopathies. Neurologic Clinics. doi:10.1016/j.ncl.2020.04.003
12. Paterson, R. W., Brown, R. L., Benjamin, L.,…Vivekanandam, V.,. . . Zandi, M. S. (2020). The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain, 143 (10), 3104-3120. doi:10.1093/brain/awaa240
13. Paterson, R. W., Brown, R. L., Vivekanandam V., … Zandi M. S., for the UCL Queen Square National Hospital for Neurology and Neurosurgery COVID-19 Study Group, (2020). Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?, Brain, 143 (10), 1-2. doi.org/10.1093/brain/awaa377
14. Suetterlin, K., Vivekanandam, V., James, N., Sud, R., Holmes, S., Fialho, D., . . . Matthews, E. (2019). Annual renal ultrasound may prevent acute presentation with acetazolamide-associated urolithiasis. Neurology: Clinical Practice. October 00; 1-3. doi:10.1212/CPJ.0000000000000761
15. Suetterlin, K., ... Vivekanandam, V.,…Matthews, E. (2020). Andersen-Tawil Syndrome Presenting with Complete Heart Block. J Neuromuscul Dis. Oct. doi: 10.3233/JND-200572.
16. Thor, M. G., Vivekanandam, V., Sampedro-Castañeda, M., Tan, S. V., Suetterlin, K., Sud, R., . . . Männikkö, R. (2019). Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation. Sci Rep, 9 (1), 17560. doi:10.1038/s41598-019-54041-0
17. Khoo, A., Smyth, D., & Vivekanandam, V. (2020). COVID-19 in a UK neurology hospital: Australasian Fellows facing Covid-19. Internal Medicine Journal. 50. 10.1111/imj.14925.
18. Vivekanandam V, Hoskote C, Rossor AM, Reilly MM. (2019) CNS phenotype in X linked Charcot- Marie-Tooth disease. Journal of Neurology, Neurosurgery & Psychiatry. Dec. 90:1068.
19. Vivekanandam, V., Li, V., Wu, T., … Mitchell, P. (2020). Cerebrospinal fluid cannot be used to distinguish inflammatory myelitis from congestive myelopathy due to spinal dural arteriovenous fistula: case series. BMJ Neurology Open 2019; 1:e000019. doi: 10.1136/bmjno-2019-000019
20. Vivek V, Kalincik T, Kilpatrick TJ, Butzkueven H et al; on behalf of the MSBase Study Group. (2013) Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain; 136: 3609-17.
21. Vivek V, Kavar B, Hogg M, Butzkueven H. (2013) Aspergillus arachnoiditis post intrathecal baclofen pump insertion. Journal of Clinical Neuroscience; 20(8):1159-60.